184 related articles for article (PubMed ID: 31957902)
1. Significant decrease in the prevalence of hepatitis C infection after the introduction of direct acting antivirals.
Rodríguez-Tajes S; Domínguez Á; Carrión JA; Buti M; Quer JC; Morillas RM; López C; Torras X; Baliellas C; Vergara M; Forner M; Zaragoza N; Salò J; Rigau J; Caballeria L; Mariño Z; Janè M; Colom J; Forns X; Lens S
J Gastroenterol Hepatol; 2020 Sep; 35(9):1570-1578. PubMed ID: 31957902
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hepatitis B and C viral infections in Ladakh region.
Khan MA; Zargar SA; Upadhyay J; Lone TA; Aggarwal R; Bashir G; Ali M; Rabyang S; Namgyal T; Wani ZA
Indian J Gastroenterol; 2018 Nov; 37(6):504-510. PubMed ID: 30543047
[TBL] [Abstract][Full Text] [Related]
4. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
[TBL] [Abstract][Full Text] [Related]
5. HBsAg and anti-HCV screening in elderly hospitalized patients of a German tertiary referral centre.
Kant J; Kratzsch J; Maier M; Liebert UG; Berg T; Wiegand J
Z Gastroenterol; 2016 Mar; 54(3):231-7. PubMed ID: 27043886
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
[TBL] [Abstract][Full Text] [Related]
8. Mass screening for hepatitis B and C in Southern Upper Egypt.
Soliman G; Elzalabany MS; Hassanein T; Miller FD
BMC Public Health; 2019 Oct; 19(1):1326. PubMed ID: 31640639
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees.
Sypsa V; Hadjipaschali E; Hatzakis A
Eur J Epidemiol; 2001; 17(8):721-8. PubMed ID: 12086089
[TBL] [Abstract][Full Text] [Related]
10. Missed hepatitis b/c or syphilis diagnosis among Kurdish, Russian, and Somali origin migrants in Finland: linking a population-based survey to the national infectious disease register.
Tiittala P; Ristola M; Liitsola K; Ollgren J; Koponen P; Surcel HM; Hiltunen-Back E; Davidkin I; Kivelä P
BMC Infect Dis; 2018 Mar; 18(1):137. PubMed ID: 29558910
[TBL] [Abstract][Full Text] [Related]
11. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
Parry JV; Easterbrook P; Sands AR
BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Hepatitis B and C virus infection among alcoholic individuals: importance of screening and vaccination.
Cortes VF; Taveira A; Cruz HM; Reis AA; Cezar JS; Silva BS; D'Assunção CF; Lampe E; Villar LM
Rev Inst Med Trop Sao Paulo; 2017; 59():e47. PubMed ID: 28793018
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus and hepatitis C virus infections in Belgium: similarities and differences in epidemics and initial management.
De Vroey B; Moreno C; Laleman W; van Gossum M; Colle I; de Galocsy C; Langlet P; Robaeys G; Orlent H; Michielsen P; Delwaide J; Reynaert H; D'Heygere F; Sprengers D; Bourgeois S; Assene C; Vos B; Brenard R; Adler M; Henrion J; Deltenre P
Eur J Gastroenterol Hepatol; 2013 May; 25(5):613-9. PubMed ID: 23325285
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania.
Voiculescu M; Iliescu L; Ionescu C; Micu L; Ismail G; Zilisteanu D; Radasan A; Micu G; Pertache I
J Gastrointestin Liver Dis; 2010 Mar; 19(1):43-8. PubMed ID: 20361074
[TBL] [Abstract][Full Text] [Related]
17. Serological markers and risk factors for hepatitis B and hepatitis C viruses among students in a Nigerian university.
Forbi J; Pennap G; Silas-Ndukuba C; Agabi Y; Agwale S
East Afr J Public Health; 2009 Aug; 6(2):152-5. PubMed ID: 20000021
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associated risk factors for Hepatitis B and C viruses among refugees in Gambella, Ethiopia.
Ayele A; Abera D; Hailu M; Birhanu M; Desta K
BMC Public Health; 2020 May; 20(1):721. PubMed ID: 32429964
[TBL] [Abstract][Full Text] [Related]
19. Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.
Woldegiorgis AE; Erku W; Medhin G; Berhe N; Legesse M
PLoS One; 2019; 14(12):e0226890. PubMed ID: 31887192
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
Merza MA; Haji SM; Alsharafani AM; Muhammed SU
Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
